www.vipartners.ch Open in urlscan Pro
2a05:d014:275:cb01::c8  Public Scan

Form analysis
0 forms found in the DOM

Text Content

VI PARTNERS

Open Menu
 * Portfolio
 * News
 * About
   * Team
   * Philosophy
   * Heritage
 * Contact

 * Portfolio
 * News
 * About
   * Team
   * Philosophy
   * Heritage
 * Contact




OUR FEATURED CONTENT

Tech – Jan 23, 2023


SWITZERLAND-BASED ACODIS CLOSES CHF 6 MILLION SERIES A FUNDING ROUND TO
TRANSFORM DOCUMENT PROCESSING FOR PHARMA AND HEALTH

The Swiss AI start-up Acodis closed a CHF 6m financing round from existing and
new investors. Acodis, the leading Intelligent Document Processing (IDP)
platform, raised CHF 6 million in a Series A funding round led by Hi Inov and VI
Partners. The new funds will be used to further expand Acodis' position as the
leading Document Processing Platform for the Pharma and Health sector.

Read the full story

Tech – Apr 25, 2024


NAVIGATING YOUR TECH CAREER, A VENTURE CAPITALIST’S PERSPECTIVE

Over the years of working as a venture capitalist, I have had the opportunity to
connect with and advise many talented individuals within the entrepreneurial
community, including experienced tech engineers. During my conversations with
numerous talented software developers, I've noticed a common trend...

Read the full story

– Mar 19, 2024


EXPLORING AI AGENTS: THE EVOLUTION FROM CHATBOTS TO INTELLIGENT AUTONOMOUS
SYSTEMS

We recently had the chance to sit down with our friend and entrepreneur, Stelio
Tzonis, to discuss the increasing role of Artificial Intelligence (AI) in
venture capital in a context where reports show that AI now accounts for 25% of
all U.S. venture investments. We discussed how the emergence of Large Language
Models affects the stock market, evidenced by NVIDIA's skyrocketing value and
the overall "hype" around AI technologies.

Read the full story

Tech – Feb 13, 2024


THE MOST CONVENIENT & SMART WAY TO LEASE ANY CAR, ANYWHERE - WHY WE INVESTED IN
LEASETEQ

Vi Partners led the Series A round of LeaseTeq, a company on a mission to offer
the world’s most convenient and smart way to lease any car, anywhere.

Read the full story

Healthcare – Feb 01, 2024


VENTURE CAPITAL MARKET EVOLUTION IN 2023

2023 is behind us and what a year it was. Let’s review the year in digital
healthcare investing and find out how much we achieved, despite the challenging
environment.

Read the full story

Tech – Dec 21, 2023


VI PARTNERS ANNOUNCE A NEW CHF 8 MIO. SERIES A INVESTMENT IN LEASETEQ

Successful closing of Series A financing round LeaseTeq and Vi Partners are
thrilled to announce the successful completion of a Series A financing round – a
pivotal moment in the journey to redefine leasing through cutting-edge
technology. With CHF 8m in a first closing and CHF 10m total round size.

Read the full story

Tech – Dec 19, 2023


TOP SWISS BANKS EMBRACE GENAI TRANSFORMATION WITH UNIQUE FINANCEGPT

Unique AG, the Swiss-based AI-driven FinanceGPT company, announced an official
go-live with their client Pictet Group. This rollout enables over 5,000
employees to experience the power of One.Chat, a platform co-developed together
with Pictet that allows easy access to all internal information.

Read the full story

Health – Dec 19, 2023


STUDY PUBLISHED IN NATURE DIGITAL MEDICINE SHOWS POTENTIAL PREDICTIVE POWER OF
AUGMENTED REALITY-BASED COGNITIVE AND FUNCTIONAL ASSESSMENT FOR ALZHEIMER’S
DISEASE

Altoida announced today results from the RADAR-AD consortium study, published in
Nature Digital Medicine, which evaluated its augmented reality (AR) and machine
learning (ML)-based digital cognitive assessment for the early identification of
individuals with Alzheimer’s Disease (AD).

Read the full story

Health + Tech – Nov 13, 2023


PUSHING BOUNDARIES: VI PARTNERS CEO DAY 2023

The Vi Partners CEO Day was a vibrant gathering of innovative minds and spirited
discussions. We were honoured to host our portfolio companies' founders, our
esteemed investors, and various key players from the ecosystem.

Read the full story

Healthcare – Nov 08, 2023


ARARIS BIOTECH AG ANNOUNCES RESEARCH COLLABORATION WITH TAIHO PHARMACEUTICAL TO
DEVELOP NEXT-GENERATION ADCS USING ARARIS’ PROPRIETARY LINKER-CONJUGATION
TECHNOLOGY

Araris, the Swiss oncology biotech company developing next-generation antibody
drug conjugates (ADCs), today announced they have entered a collaboration
agreement under which Araris will use its proprietary linker-conjugation
platform to generate novel ADCs against undisclosed targets provided by Taiho
Pharmaceutical Co., Ltd., a Japanese R&D-driven specialty pharma company with a
focus on oncology.

Read the full story

Healthcare – Oct 24, 2023


JENAVALVE ANNOUNCES LATE-BREAKING DATA FROM THE ALIGN-AR PIVOTAL TRIAL MEETING
SAFETY AND EFFICACY ENDPOINTS

The developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV)
System, today announced results from the ALIGN-AR Pivotal Trial for the Trilogy
THV System in high-risk patients with symptomatic, severe aortic regurgitation
(AR).

Read the full story

Tech – Oct 05, 2023


NINOX INTRODUCES FLEXIBLE CRM FOR SMBS BASED ON LOW-CODE.

Leading Berlin-based software provider Ninox is setting a milestone in the world
of business applications with the market launch of Ninox CRM. Thanks to
low-code, the flexible and individually customizable complete solution allows
the continuous digitization of processes on a single platform.

Read the full story

Tech – Sep 27, 2023


UNLOCKING STARTUP POTENTIAL: THE VI PARTNERS 4PS BLUEPRINT

At Vi Partners, we're not just about crunching numbers; we're treasure hunters.
What are we digging for? The future leaders of the B2B SaaS universe,
particularly in Europe and Switzerland.

Read the full story

Healthcare – Aug 14, 2023


XELTIS SECURES ADDITIONAL €12.5 MILLION FROM EUROPEAN INNOVATION COUNCIL FUND IN
FINAL CLOSE OF D2 FINANCING

Funding extends Xeltis’ Series D2 financing round to €44.5 million.

Read the full story

Healthcare – Aug 08, 2023


OCULIS ANNOUNCE POSITIVE RESULTS FROM A PHASE 3 OPTIMIZE TRIAL SHOWING THAT A
DAILY DOES OF OCS-01 EYE DROPS TREATS INFLAMMATION AND PAIN FOLLOWING CATARACT
SURGERY

OCS-01, First Investigational Eye Drop for Front and Back of the Eye, Met Both
Primary Endpoints in Phase 3 OPTIMIZE Trial with a Once Daily Regimen for the
Treatment of Inflammation and Pain Following Cataract Surgery Once daily OCS-01
meets primary endpoints demonstrating superior reduction in inflammation and
pain vs. vehicle following cataract surgery OPTIMIZE’s results follow the
positive and statistically significant top line results from stage 1 of the
Phase 3 DIAMOND trial in Diabetic Macular Edema (DME) reported earlier this
year, further highlighting the product’s potential for treating front- and
back-of-the-eye diseases

Read the full story

Healthcare – Jul 12, 2023


EMPOWERING BREAST CANCER SCREENING GLOBALLY - WHY WE INVESTED IN VARA

Last year, Vi Partners led a Series A2 round in Vara (www.vara.ai), a pioneering
company focused on democratising breast cancer screening and improving women's
healthcare outcomes. We are thrilled to partner with Vara's exceptional team,
who are driven by the ambition to transform how breast cancer screenings are
conducted, ensuring accessibility, accuracy, and a patient-centric approach.

Read the full story
Vara


Healthcare – Jul 05, 2023


BUILDING THE DIGITAL HEALTHCARE ENTERPRISE ECOSYSTEM – CUSTOMER BY CUSTOMER

Giving European Healthcare enterprises, a digital upgrade is hard. Let’s explore
the challenges and some of the lights on the horizon. The prosperity and health
of all of us depends on keeping our health care systems effective. To make sure
this is achieved and remains affordable, we need to leverage digital
transformation.

Read the full story
Blog


Healthcare – May 22, 2023


OCULIS ANNOUNCES POSITIVE TOP LINE RESULTS

Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in
Diabetic Macular Edema with OCS-01 Eye Drops

Read the full story

Technology – Feb 27, 2023


WHY DID WE INVEST IN TIME MANAGEMENT APPLICATION MORGEN.SO?

Last summer, the Vi Partners technology team led a pre-seed round in Morgen.so.
We are delighted to partner with a ground breaking time management application
built by a stellar team that has the ambition to transform how knowledge workers
deal with their time, boost their productivity while improving their worklife
balance and overall wellbeing.

Read the full story

Healthcare – Feb 21, 2023


XELTIS RAISES €32 MILLION TO DRIVE CLINICAL DEVELOPMENT OF WORLD’S MOST ADVANCED
RESTORATIVE CARDIOVASCULAR DEVICES

Xeltis, a clinical stage medtech company developing living implants that enable
the body to restore cardiovascular function, announces that it has raised €32
million in a Series D2 equity fundraise.

Read the full story

Tech – Jan 23, 2023


SWITZERLAND-BASED ACODIS CLOSES CHF 6 MILLION SERIES A FUNDING ROUND TO
TRANSFORM DOCUMENT PROCESSING FOR PHARMA AND HEALTH

The Swiss AI start-up Acodis closed a CHF 6m financing round from existing and
new investors. Acodis, the leading Intelligent Document Processing (IDP)
platform, raised CHF 6 million in a Series A funding round led by Hi Inov and VI
Partners. The new funds will be used to further expand Acodis' position as the
leading Document Processing Platform for the Pharma and Health sector.

Read the full story

Tech – Apr 25, 2024


NAVIGATING YOUR TECH CAREER, A VENTURE CAPITALIST’S PERSPECTIVE

Over the years of working as a venture capitalist, I have had the opportunity to
connect with and advise many talented individuals within the entrepreneurial
community, including experienced tech engineers. During my conversations with
numerous talented software developers, I've noticed a common trend...

Read the full story




LATEST NEWS

 * Insights & Thoughts – Apr 25, 2024
   
   
   NAVIGATING YOUR TECH CAREER, A VENTURE CAPITALIST’S PERSPECTIVE
   
   Read More
 * Insights & Thoughts – Mar 19, 2024
   
   
   EXPLORING AI AGENTS: THE EVOLUTION FROM CHATBOTS TO INTELLIGENT AUTONOMOUS
   SYSTEMS
   
   Read More
 * Portfolio – Feb 12, 2024
   
   
   THE MOST CONVENIENT & SMART WAY TO LEASE ANY CAR, ANYWHERE - WHY WE INVESTED
   IN LEASETEQ
   
   Read More

See all news
Our credo

> Entre­preneurs improve the world. We proudly support them.

Our heritage


WHO WE ARE AND HOW WE STARTED 


Vi Partners' founding team came together in 2000 to advise Venture Incubator, an
investment vehicle initiated by ETHZ and funded by ten blue-chip Swiss
companies. Today, we advise funds investing across Europe in tech and
healthcare.

More about our heritage
Meet the team
 * ©2001 – 2023 VI Partners
 * Privacy Policy
 * Imprint

Follow us on LinkedIn


COOKIES

We use our own cookies and third-party cookies so that we can show you this
website and better understand how you use it, with a view to improving the
services we offer.

Privacy Policy
Manage cookies Accept all